IPCA-Zopiclone

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Zopiclone 3.75mg;  

Disponibbli minn:

Ipca Pharma (NZ) Pty Limited

INN (Isem Internazzjonali):

Zopiclone 3.75 mg

Dożaġġ:

3.75 mg

Għamla farmaċewtika:

Film coated tablet

Kompożizzjoni:

Active: Zopiclone 3.75mg   Excipient: Calcium hydrogen phosphate dihydrate Colloidal silicon dioxide Hypromellose Indigo carmine aluminium lake Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Povidone Purified talc Sodium starch glycolate Titanium dioxide

Tip ta 'preskrizzjoni:

Class C5 Controlled Drug

Manifatturat minn:

Centaur Pharmaceuticals Private Limited

Indikazzjonijiet terapewtiċi:

Treatment of transient, short-term and chronic insomnia in adults including difficulties with falling asleep, nocturnal awakening and wakening.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Blister pack, PVC/Al in outer cardboard carton - 28 tablets - 36 months from date of manufacture stored at or below 25°C protect from light

Data ta 'l-awtorizzazzjoni:

2013-06-14